Search research articles
Contact Us
Filters
Showing results (231-240 of 327) with videos related to
Page
of 33
Sort By:
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Blut
|
May 1, 1988
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia
E Kurrle, G Ehninger, M Freund, et al.
Blut
|
February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha
R Hehlmann, B Anger, D Messerer, et al.
Cancer Treatment Reports
|
April 1, 1986
Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer
G Schnitzler, W Queisser, M E Heim, et al.
Mbio
|
February 8, 2022
Nitrate Is an Environmental Cue in the Gut for Salmonella enterica Serovar Typhimurium Biofilm Dispersal through Curli Repression and Flagellum Activation via Cyclic-di-GMP Signaling
Amanda L Miller, Lauren K Nicastro, Shingo Bessho, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Blood
|
August 19, 2025
Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Rebecca A Mellema, Kimberly A Queisser, Abigail Ajanel, et al.
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Blood
|
December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Onkologie
|
February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 327) with videos related to
Sort By:
Page
of 33
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Blut
|
May 1, 1988
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia
E Kurrle, G Ehninger, M Freund, et al.
Blut
|
February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha
R Hehlmann, B Anger, D Messerer, et al.
Cancer Treatment Reports
|
April 1, 1986
Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer
G Schnitzler, W Queisser, M E Heim, et al.
Mbio
|
February 8, 2022
Nitrate Is an Environmental Cue in the Gut for Salmonella enterica Serovar Typhimurium Biofilm Dispersal through Curli Repression and Flagellum Activation via Cyclic-di-GMP Signaling
Amanda L Miller, Lauren K Nicastro, Shingo Bessho, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Blood
|
August 19, 2025
Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Rebecca A Mellema, Kimberly A Queisser, Abigail Ajanel, et al.
Onkologie
|
July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
G. Hartung, R. Hofheinz, D. Buchheidt, et al.
Blood
|
December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Onkologie
|
February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Page
of 33